Fda Head Asks For Investigation Into Connection Between Aduhelm Maker Drug Reviewers
Dr. Janet Woodcock said on Twitter she had requested that the Department of Health and Human Services, which supervises the FDA, look into the circumstances of the drug’s approval. Two congressional committees have already initiated their own probe into the green-lighting of Aduhelm, whose effectiveness is unproven, the AP said. “We believe an independent assessment is the best manner in which to determine whether any interactions that occurred between the manufacturer and the agency’s review staff were inconsistent with FDA’s policies and procedures,” Woodcock said....